Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma

• Main Authors: Ng K.Y.Y., Tan S.H., Tan J.J.E., Tay D.S.H., Lee A.W.X., Ang A.J.S., Wong L.W.J., Choo S.P., Tai D.W.-M., Lee J.J.X.
• Other Authors: DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)
• Format: Article
• Published: S. Karger AG 2022
• Subjects: Hepatocellular carcinoma; Immune checkpoint inhibitors; Immune-related adverse events; Survival; Response
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/214278
• Institution: National University of Singapore

10.1159/000518619